249 related articles for article (PubMed ID: 24664)
1. Effects of restoring lethally irradiated mice with anti-Thy 1.2-treated bone marrow: graft-vs-host, host-vs-graft, and mitogen reactivity.
Norin AJ; Emeson EE
J Immunol; 1978 Mar; 120(3):754-8. PubMed ID: 24664
[TBL] [Abstract][Full Text] [Related]
2. Effect of selective T cell depletion of host and/or donor bone marrow on lymphopoietic repopulation, tolerance, and graft-vs-host disease in mixed allogeneic chimeras (B10 + B10.D2----B10).
Ildstad ST; Wren SM; Bluestone JA; Barbieri SA; Stephany D; Sachs DH
J Immunol; 1986 Jan; 136(1):28-33. PubMed ID: 2933464
[TBL] [Abstract][Full Text] [Related]
3. Antilymphocytic antibodies and marrow transplantation. VII. Two of nine monoclonal anti-Thy-1 antibodies used for pretreatment of donor marrow suppressed graft-versus-host reactions without added complement.
Thierfelder S; Cobbold S; Kummer U; Waldmann H; Schuh R
Exp Hematol; 1985 Oct; 13(9):948-55. PubMed ID: 2864278
[TBL] [Abstract][Full Text] [Related]
4. Long-term survival of murine allogeneic bone marrow chimeras: effect of anti-lymphocyte serum and bone marrow dose.
Norin AJ; Emeson EE; Veith FJ
J Immunol; 1981 Feb; 126(2):428-32. PubMed ID: 7451985
[TBL] [Abstract][Full Text] [Related]
5. The graft-versus-host reaction and immune function. III. Functional pre-T cells in the bone marrow of graft-versus-host-reactive mice displaying T cell immunodeficiency.
Seddik M; Seemayer TA; Lapp WS
Transplantation; 1986 Feb; 41(2):238-42. PubMed ID: 3484849
[TBL] [Abstract][Full Text] [Related]
6. Effect of the treatment of parental cells in vitro with anti-T antibody on bone marrow transplantation in F1 hybrid mice.
Hrubá A; Paluska E; Fricová V; Fiala J
Folia Biol (Praha); 1980; 26(5):338-50. PubMed ID: 7002637
[TBL] [Abstract][Full Text] [Related]
7. Reconstitution of lymphoid tissues under the influence of a subclinical level of graft versus host reaction induced by bone marrow T cells or splenic T cell subsets.
Hirano M; Arase H; Arase-Fukushi N; Ogasawara K; Iwabuchi K; Miyazaki T; Good RA; Onoé K
Cell Immunol; 1993 Oct; 151(1):118-32. PubMed ID: 8402923
[TBL] [Abstract][Full Text] [Related]
8. The effects of polyinosinic:polycytidylic acid (pI:C) on the graft-vs-host (GVH) reaction. II. Increased NK-mediated rejection on C57BL/6 lymphocytes by (C57BL/6 X A)F1 mice.
Peres A; Nestel FP; Seemayer TA; Lapp WS
J Immunol; 1986 Dec; 137(11):3420-7. PubMed ID: 3537120
[TBL] [Abstract][Full Text] [Related]
9. Use of lymphokine-activated killer cells to prevent bone marrow graft rejection and lethal graft-vs-host disease.
Azuma E; Yamamoto H; Kaplan J
J Immunol; 1989 Sep; 143(5):1524-9. PubMed ID: 2668409
[TBL] [Abstract][Full Text] [Related]
10. The influence of graft-versus-host reactivity, lymphocyte depletion, and cell dose on allogeneic bone marrow engraftment.
Glass B; Uharek L; Gaska T; Gassmann W; Löffler H; Müller-Ruchholtz W
Bone Marrow Transplant; 1993; 12 Suppl 3():S41-7. PubMed ID: 8124257
[TBL] [Abstract][Full Text] [Related]
11. Effects of T cell depletion in radiation bone marrow chimeras. III. Characterization of allogeneic bone marrow cell populations that increase allogeneic chimerism independently of graft-vs-host disease in mixed marrow recipients.
Sykes M; Chester CH; Sundt TM; Romick ML; Hoyles KA; Sachs DH
J Immunol; 1989 Dec; 143(11):3503-11. PubMed ID: 2584703
[TBL] [Abstract][Full Text] [Related]
12. Bone marrow transplantation across major histocompatability barriers in mice. III. Treatment of donor grafts with monoclonal antibodies directed against Lyt determinants.
Vallera DA; Soderling CC; Kersey JH
J Immunol; 1982 Feb; 128(2):871-5. PubMed ID: 6172513
[TBL] [Abstract][Full Text] [Related]
13. Role of the thymus in control of autoreactivity or allotolerance in syngeneic and allogeneic bone marrow chimeras treated with bacterial adjuvants.
Taniguchi K; Gondo H; Nomoto K
J Immunol; 1984 Oct; 133(4):1735-9. PubMed ID: 6088626
[TBL] [Abstract][Full Text] [Related]
14. Strain difference in the radiosensitivity of immunocompetent cells and its influence on the residual host-vs-graft reaction in lethally irradiated mice grafted with semiallogeneic bone marrow.
Sado T; Kamisaku H; Kubo E
J Immunol; 1985 Feb; 134(2):704-10. PubMed ID: 3880789
[TBL] [Abstract][Full Text] [Related]
15. The graft-versus-host reaction and immune function. II. Recruitment of pre-T-cells in vivo by graft-versus-host-induced dysplastic thymuses following irradiation and bone marrow treatment.
Seddik M; Seemayer TA; Lapp WS
Transplantation; 1984 Mar; 37(3):286-90. PubMed ID: 6142550
[TBL] [Abstract][Full Text] [Related]
16. Abrogation of bone marrow allograft resistance in mice by increased total body irradiation correlates with eradication of host clonable T cells and alloreactive cytotoxic precursors.
Schwartz E; Lapidot T; Gozes D; Singer TS; Reisner Y
J Immunol; 1987 Jan; 138(2):460-5. PubMed ID: 3098843
[TBL] [Abstract][Full Text] [Related]
17. Spontaneous and IL-2-induced anti-leukemic and anti-host effects against tumor- and host-specific alloantigens.
Cohen P; Vourka-Karussis U; Weiss L; Slavin S
J Immunol; 1993 Nov; 151(9):4803-10. PubMed ID: 8409438
[TBL] [Abstract][Full Text] [Related]
18. Facilitation of parental-strain marrow engraftment by T cells of neonatally-tolerant mice.
Davenport C; George T; Devora GA; Morris MA; Gordon BE; Kumar V; Bennett M
Biol Blood Marrow Transplant; 1997 Dec; 3(6):294-303. PubMed ID: 9502296
[TBL] [Abstract][Full Text] [Related]
19. Treatment of BCL1 leukemia by transplantation of low density fractions of allogeneic bone marrow and spleen cells.
Palathumpat V; Holm B; Dejbakhsh-Jones S; Strober S
J Immunol; 1992 May; 148(10):3319-26. PubMed ID: 1578152
[TBL] [Abstract][Full Text] [Related]
20. Regulation of cell-mediated cytotoxicity. III. Synergism of cortico-resistant with anti-thymocyte serum-resistant splenic T cells in the generation of cytotoxic lymphocytes in graft-vs-host reactions.
Babu UM; Sabbadini E
J Immunol; 1977 Aug; 119(2):781-5. PubMed ID: 18543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
